Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers
- 286 Downloads
Although numerous studies have documented that nicotine can function as an effective reinforcer of intravenous self-administration behavior in animals, it has not been clearly shown to maintain intravenous self-administration behavior above vehicle placebo levels in humans.
To compare the reinforcing effectiveness of nicotine versus saline placebo in human research volunteers responding under fixed-ratio (FR) schedules of intravenous drug self-administration while systematically increasing response requirements.
Eight male cigarette smokers resided in an inpatient research unit. During 3-h sessions, intravenous injections of nicotine and saline were available concurrently and were contingent on responding (pulling a lever). Nicotine dose (0.75, 1.5, 3.0 mg/injection), time out (TO) value after each injection (1–20 min) and FR response requirement (10–1600) were varied in different subjects over consecutive sessions.
Number of nicotine injections/session significantly decreased as dose/injection increased and the number of self-administered nicotine injections was significantly greater than the number of self-administered saline injections across conditions. When FR value was progressively increased over sessions, response rates for nicotine, but not saline, injections increased, with maximal rates at the highest FR values. Rates of responding and injections/session were markedly and significantly higher for nicotine than for saline at FR values of 200 and above. Subjects rated effects of nicotine as both significantly more positive and more negative than saline placebo, with positive ratings significantly higher than negative ratings.
Nicotine functioned as a prototypic drug of abuse, serving as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Subjects adjusted their responding to response requirements in a way that maintained relatively constant levels of nicotine injections per session.
KeywordsNicotine Human Tobacco, smoking behavior Drug self-administration Intravenous Fixed-ratio schedule
This study was supported by NIDA, NIH and DHHS. We would like to thank Drs. David Epstein and Zuzana Justinova for their help in analyzing the data and Mr. Richard Taylor for his help in retrieving subject histories.
- Ettenberg A, Geist TD (1991) Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology 103:455–461Google Scholar
- Fiore MC, Bailey WC, Cohen SJ et al. (2000) Treating tobacco use and dependence, Clinical Practice Guideline. US Department of Health and Human Services, Rockville, Md.Google Scholar
- Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse. JAI Press, Greenwich, pp 1–90Google Scholar
- Henningfield JE, Goldberg SR (1983) Control of behavior by intravenous nicotine injections in human subjects. Pharmacol Biochem Behav 19:1021–1026Google Scholar
- Singer JD (1998) Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J Ed Behav Stat 24:323–355Google Scholar
- Soria R, Stapleton JM, Gilson SF, Sampson-Cone A, Henningfield JE, London ED (1996) Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology 128:221–226Google Scholar
- US Department of Health and Human Services (1988) The health consequences of smoking: Nicotine addiction (DHHS Publication No. CDC 88-8406). US Government Printing Office, Washington D.C.Google Scholar